U.S. Liquid Embolic Agent Market Size Worth USD 156.91 Million by 2034 | CAGR: 9.0%

The U.S. liquid embolic agents market size is expected to reach USD 156.91 Million by 2034, according to a new study by Polaris Market Research. The report “U.S. Liquid Embolic Agent Market Share, Size, Trends, Industry Analysis Report: By Product Type, By Application, By End User; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for liquid embolic agents in the U.S. is growing due to their extensive use in treating arteriovenous malformations (AVMs), intracranial aneurysms, and peripheral vascular abnormalities. These agents include ethylene vinyl alcohol (EVOH), cyanoacrylates, and other formulations, enable minimally invasive surgeries, faster patient recovery and improved procedural outcomes.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-liquid-embolic-agent-market/request-for-sample

Market growth is driven by rising prevalence of cerebrovascular disorders, an aging population, increasing adoption of outpatient and hospital-based neurointerventions, and technological advancements in polymer formulations and delivery systems.

Top of FormU.S. Liquid Embolic Agent Market Report Highlights

• Based on product type, the ethylene vinyl alcohol copolymer (EVOH) segment dominated the market in 2024, driven by clinical reliability, strong physician preference, and established procedural outcomes.
• In terms of application, the arteriovenous malformations (AVM) led the market in 2024 due to high procedural frequency and demand for precise embolization.
• Based on end users, the hospitals held the largest share in 2024, fueled by advanced imaging infrastructure, trained specialists, and integrated neurointervention suites.
• A few global key market players include Medtronic plc, Johnson & Johnson, Stryker Corporation, Terumo Corporation, Sirtex Medical Inc., Boston Scientific Corporation, Instylla, Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet Group S.A, Arsenal Medical Inc., and Meril Life Sciences Pvt. Ltd.

Polaris Market Research has segmented the market report on the basis of product type, application, end user:

By Product Type Outlook (Revenue, USD Million, 2020–2034)

• Ethylene Vinyl Alcohol Copolymer (EVOH)
• Cyanoacrylates
  • N-BCA (n-Butyl Cyanoacrylate)
  • N-HCA (n-Hexyl Cyanoacrylate)
• Other Products

By Application Outlook (Revenue, USD Million, 2020–2034)

• Arteriovenous Malformations (AVM)
• Hypervascular Tumors
• Peripheral Vasculature Hemorrhage
• Other Applications

By End User Outlook (Revenue, USD Million, 2020–2034)

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Other End Users